T43 ICD-10-CM Code: Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified
Billing Status: NO. This is a clinician non-billable / parent hierarchy grouping in the ICD-10-CM system.
Coding at a Glance
- 7th character
- Required — characters A · D · S
Coding instructions
Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for T43 in the official ICD-10-CM tabular list, quoted as published.
Notes without a marker are published on T43 itself; “inherited from” names the category or block whose note applies here.
Includes
Conditions the official ICD-10-CM tabular list includes under this code.
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Source: inherited from T36-T50
Excludes1 — Not Coded Here
Conditions generally not reported together with this code (Excludes1) -- an error unless the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
- toxic reaction to local anesthesia in pregnancy (O29.3-) Compare T43 vs O29.3 →
Source: inherited from T36-T50
Excludes2 — Not Included Here
Conditions not covered by this code, but which may be reported alongside it when both are present.
- appetite depressants (T50.5-) Compare T43 vs T50.5 →
- barbiturates (T42.3-) Compare T43 vs T42.3 →
- benzodiazepines (T42.4-) Compare T43 vs T42.4 →
- drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.- -F19.-) Compare T43 vs F10 →
- methaqualone (T42.6-) Compare T43 vs T42.6 →
- psychodysleptics hallucinogens
- abuse and dependence of psychoactive substances (F10-F19) inherited from T36-T50Compare T43 vs F10 →
- abuse of non-dependence-producing substances (F55.-) inherited from T36-T50Compare T43 vs F55 →
- immunodeficiency due to drugs (D84.821) inherited from T36-T50Compare T43 vs D84.821 →
- drug reaction and poisoning affecting newborn (P00-P96) inherited from T36-T50Compare T43 vs P00 →
- pathological drug intoxication (inebriation) (F10-F19) inherited from T36-T50Compare T43 vs F10 →
Code First
Underlying conditions that must be sequenced before this code.
- Code first, for adverse effects, the nature of the adverse effect, such as:
- adverse effect NOS (T88.7)
- aspirin gastritis (K29.-)
- blood disorders (D56-D76)
- contact dermatitis (L23-L25)
- dermatitis due to substances taken internally (L27.-)
- nephropathy (N14.0-N14.2)
Source: inherited from T36-T50
Use Additional Code
Supplementary codes the tabular list directs you to add.
- Use additional code(s) to specify:
- manifestations of poisoning
- underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
- underdosing of medication regimen (Z91.12-, Z91.13-)
Source: inherited from T36-T50
7th Character Guide
"The appropriate 7th character is to be added to each code from category T43"
- A — initial encounter
- D — subsequent encounter
- S — sequela
How the encounter character is assigned. “Initial encounter” means the patient is receiving active treatment for the condition — it is not limited to the first visit, and a different or new provider giving active treatment still assigns it. “Subsequent encounter” covers care during the healing or recovery phase after active treatment. “Sequela” is for complications or conditions that arise as a direct result of the original condition.
ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.19.a (paraphrased by MedCoder).
Variant codes in this family
T43.011A, T43.011D, T43.011S, T43.012A, T43.012D, T43.012S, T43.013A, T43.013D
Character meanings are CMS's official 7th-character extensions for this family, as carried in each variant code's official description; variant codes are registry rows. The explanation of how the encounter character is assigned is MedCoder editorial, distinct from the official content above it.
Coder workflow for T43
MedCoder structured workflow — derived from this code’s own official record
Before you code T43
- T43 is not reportable as written. Select the more specific code beneath it that the documentation supports. Codes are reported to the highest level of specificity the classification provides (Guidelines I.B.2).
ReviewT43.0, T43.1, T43.2, T43.3, T43.4, T43.5, T43.6
See the relationships section · Guide: How to choose an ICD-10-CM code →
- “Other” (NEC) means the condition is specified in the record but no dedicated code captures it. Confirm the documented form is not one a sibling code names before settling on T43; if the record states no specifics at all, the unspecified sibling applies instead. “Other” codes are for documented conditions the classification gives no specific code; “unspecified” codes are for records lacking the detail (Guidelines I.A.9.a, I.A.9.b).
See the relationships section · Guide: Other vs unspecified (NEC vs NOS) →
- A 7th character is required in this family. Confirm the documented encounter: initial (active treatment), subsequent (healing or recovery phase), or sequela. T43 is not valid without one. “Initial” means active treatment, not the first visit (Guidelines I.C.19.a).
See the 7th Character Guide · Guide: 7th characters: initial, subsequent, sequela →
- Confirm whether the documentation describes a poisoning, an adverse effect of a correctly prescribed and administered drug, an underdosing, or a toxic effect, and the intent where the record states it: the Table of Drugs and Chemicals separates these by column, and the sequencing differs for each. Poisoning, adverse effect and underdosing guidelines (Guidelines I.C.19.e).
See the Table of Drugs and Chemicals entries · Guide: Poisoning vs adverse effect vs underdosing →
- Check the Excludes1 note: if the documentation supports a condition named there, do not simply proceed with T43. Excludes1 conditions are not reported together with this code unless the record shows they are unrelated (Guidelines I.A.12.a).
Choose the right path
- Does the documentation support one of the more specific codes beneath T43?
Yes → Select that code and continue the checks below on its own page.
No → T43 cannot be reported as written; query for the specificity its subcategory needs. - Does the documentation support a condition named in T43’s Excludes1 note?
Yes → Do not simply proceed: review the excluded code. Both are reported only when the record shows the two conditions are unrelated.
No → Continue.ReviewO29.3
- Is the underlying (etiologic) condition the Code First note names documented?
Yes → Sequence the underlying condition first, then T43.
No → Continue; do not add an underlying condition the record does not document. - Is the encounter phase documented — active treatment, healing or recovery, or a sequela?
Yes → Assign the matching 7th character; the variant codes are in the 7th Character Guide.
No → The code is invalid without its 7th character — query for the missing element.
Consider T43. Then work the Use Additional Code note, and confirm the code is valid for the date of service in the Verify section.
Documentation check
- The provider’s diagnostic statement
- Codes are assigned from the provider’s documented diagnosis, not from clinical criteria, test values or a medication list (Guidelines I.A.19).
- Encounter type
- Active treatment, healing or recovery phase, or sequela — the basis of the 7th character (Guidelines I.C.19.a).
- The underlying (etiologic) condition
- Named in the Code First note; sequenced before this code when documented (Guidelines I.A.13).
- The conditions the Use Additional Code note names
- Reported with this code when documented; a conditional instruction (“if applicable”, “if known”) applies only when the record supports it.
- External cause, place and activity
- For the external cause codes reported with the injury or poisoning, where documented (Guidelines I.C.20.a).
- Any detail beyond this code’s title
- What the record states that a more specific sibling code would capture — or its absence, which itself supports the unspecified code.
Official instructions as workflow
Excludes1 — check before selecting T43(1 note)
Coding workflow: If the documentation supports a condition named in this note, do not simply proceed with T43: the two are not reported together. The one exception is when the record shows the two conditions are unrelated to each other.
CompareO29.3
See the official tabular notes · Guidelines I.A.12.a
Excludes2 — not part of T43(11 notes)
Coding workflow: The conditions named in this note are not included in T43. When the record documents both, both may be reported; the note is a boundary, not a prohibition.
CompareT50.5, T42.3, T42.4, F10, F19, T42.6
See the official tabular notes · Guidelines I.A.12.b
Code First — sequencing check(7 notes)
Coding workflow: Check whether the underlying or etiologic condition the note names is documented. When it is, sequence it before T43. Do not add an underlying condition the record does not document.
See the official tabular notes · Guidelines I.A.13
Use Additional Code — after identifying T43(4 notes)
Coding workflow: Check whether the documentation supports the additional code(s) the note names, and report them with T43 when it does. Where the instruction is conditional (“if applicable”, “if known”), it applies only when the record documents the condition.
See the official tabular notes · Guidelines I.A.13
Coding decision scenarios
Pattern scenarios for this code’s structure — decision rules, not clinical cases
Documentation: Both the condition T43 describes and a condition named in its Excludes1 note are documented for the same encounter.
Coding question: Can both codes be reported?
Path: Review the Excludes1 note and the excluded code, and look for a provider statement on whether the two conditions are related.
Reason: Excludes1 means the two are not coded together; the exception is when the record shows the conditions are unrelated to each other (Guidelines I.A.12.a).
ReviewO29.3
Documentation: The patient returns during the healing or recovery phase after active treatment of the same condition.
Coding question: Which 7th character applies?
Path: Review the official 7th-character definitions for this family in the 7th Character Guide.
Reason: “Initial encounter” means active treatment, not the first visit; care during recovery takes “subsequent encounter”, and a complication arising from the original condition takes “sequela” (Guidelines I.C.19.a).
Documentation: The underlying condition the Code First note names is documented alongside this condition.
Coding question: How are the two sequenced?
Path: Review the Code First note.
Reason: The underlying condition is sequenced first and the manifestation follows (Guidelines I.A.13).
Every row is derived from this code’s own record — its title, tabular notes, 7th-character family and same-category siblings — with fixed MedCoder wording; nothing is inferred about a patient. The official notes and guideline text are in the sections each row links to, and they control.
Code Overview
MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.
Decision Points
The directives on this code's own record, as a pre-claim checklist.
- A 7th character applies in this family. Confirm the documented encounter matches the character assigned. See the official 7th-character definitions and this code’s variants
- Sequencing: 7 Code First instructions — the underlying condition is sequenced before this code when present. See the Code First notes
- 4 Use Additional Code instructions — report the named additional code(s) when the documentation supports them. See the Use Additional Code notes
- 1 Excludes1 entry — codes named there are generally not reported together with this code (Guidelines I.A.12.a). See the Excludes1 notes
- 11 Excludes2 entries — those conditions are not part of this code and may be reported additionally when documented. See the Excludes2 notes
Checklist rows are derived from this code's own official directives; the wording of each check is MedCoder editorial. The official notes themselves are in the sections each row links to.
Verify Before Coding
- Not billable as written — a more specific code is required: T43.011A, T43.011D, T43.011S, T43.012A, T43.012D.
- Requires a 7th character. "The appropriate 7th character is to be added to each code from category T43" Options: T43.011A, T43.011D, T43.011S, T43.012A, T43.012D, T43.012S
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.
Relationships & Classification
MedCoder structured relationships — computed from published CMS and AHRQ datasets
Other codes that name T43 or its code family, from the CMS ICD-10-CM tabular instructional notes. Tabular-note edges are stored at the code family level that carries each note.
Referenced by 11 Excludes2 notes across 2 chapters: T80 — Complications following infusion, transfusion and therapeutic injection, T80-T88 — Complications of surgical and medical care, not elsewhere classified (T80-T88), T81 — Complications of procedures, not elsewhere classified, T82 — Complications of cardiac and vascular prosthetic devices, implants and grafts, T83 — Complications of genitourinary prosthetic devices, implants and grafts, T84 — Complications of internal orthopedic prosthetic devices, implants and grafts, T85 — Complications of other internal prosthetic devices, implants and grafts, T86 — Complications of transplanted organs and tissue, T87 — Complications peculiar to reattachment and amputation, T88 — Other complications of surgical and medical care, not elsewhere classified, Y63 — Failure in dosage during surgical and medical care.
These codes’ tabular lists name this diagnosis as distinct — both may be reported when both are documented.
Referenced by 20 Code First instructions across 13 chapters: D64.2 — Secondary sideroblastic anemia due to drugs and toxins, E03.2 — Hypothyroidism due to medicaments and other exogenous substances, E09 — Drug or chemical induced diabetes mellitus, F02 — Dementia in other diseases classified elsewhere, G92.8 — Other toxic encephalopathy, G92.9 — Unspecified toxic encephalopathy, H35.38 — Toxic maculopathy, H91.0 — Ototoxic hearing loss, I42.7 — Cardiomyopathy due to drug and external agent, K22.1 — Ulcer of esophagus, K71 — Toxic liver disease, L53.0 — Toxic erythema, M34.2 — Systemic sclerosis induced by drug and chemical, N14 — Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions, P58.4 — Neonatal jaundice due to drugs or toxins transmitted from mother or given to newborn, Z91.12 — Patient's intentional underdosing of medication regimen, Z91.13 — Patient's unintentional underdosing of medication regimen, Z91.14 — Patient's other noncompliance with medication regimen, Z91.A2 — Caregiver's intentional underdosing of patient's medication regimen, Z91.A3 — Caregiver's unintentional underdosing of patient's medication regimen.
Each of these codes carries a Code First note naming this condition — when that code is reported, THIS code is sequenced first, ahead of it.
Referenced by 99 Use Additional Code instructions across 15 chapters: D46 — Myelodysplastic syndromes, D52.1 — Drug-induced folate deficiency anemia, D59.0 — Drug-induced autoimmune hemolytic anemia, D59.2 — Drug-induced nonautoimmune hemolytic anemia, D59.39 — Other hemolytic-uremic syndrome, D61.1 — Drug-induced aplastic anemia, D64.2 — Secondary sideroblastic anemia due to drugs and toxins, D70.2 — Other drug-induced agranulocytosis, D72.12 — Drug rash with eosinophilia and systemic symptoms syndrome, D84.821 — Immunodeficiency due to drugs, D89.3 — Immune reconstitution syndrome, E03.2 — Hypothyroidism due to medicaments and other exogenous substances, E06.4 — Drug-induced thyroiditis, E09 — Drug or chemical induced diabetes mellitus, E16.0 — Drug-induced hypoglycemia without coma, E22.1 — Hyperprolactinemia, E23.1 — Drug-induced hypopituitarism, E24.2 — Drug-induced Cushing's syndrome, E25.8 — Other adrenogenital disorders, E27.3 — Drug-induced adrenocortical insufficiency, +79 more.
These codes instruct coders to additionally report this code when it applies.
Referenced by 1 Code Also instruction: Z91.1 — Patient's noncompliance with medical treatment and regimen.
These codes suggest coding this condition alongside when both are present.
Contextual Map
Every relationship of T43 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Run T43 with these 24 related codes in Claim Check
Hierarchy
- S00-T88 — Chapter 19: Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) (S00-T88)[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T36-T50 — Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T42-T43 — Anticonvulsants & Psychotropics[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
Excludes1
- O29.3 — Toxic reaction to local anesthesia during pregnancy[Excludes1]: “toxic reaction to local anesthesia in pregnancy (O29.3-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Excludes2 (17)
- D84.821 — Immunodeficiency due to drugs[Excludes2]: “immunodeficiency due to drugs (D84.821)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F10 — Alcohol related disorders[Excludes2]: “drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.- -F19.-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F11 — Opioid related disorders[Excludes2]: “abuse and dependence of psychoactive substances (F10-F19)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F12 — Cannabis related disorders[Excludes2]: “abuse and dependence of psychoactive substances (F10-F19)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F13 — Sedative, hypnotic, or anxiolytic related disorders[Excludes2]: “abuse and dependence of psychoactive substances (F10-F19)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F14 — Cocaine related disorders[Excludes2]: “abuse and dependence of psychoactive substances (F10-F19)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F15 — Other stimulant related disorders[Excludes2]: “abuse and dependence of psychoactive substances (F10-F19)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F16 — Hallucinogen related disorders[Excludes2]: “abuse and dependence of psychoactive substances (F10-F19)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- and 9 more
Code First (32)
- D56 — Thalassemia[Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D57 — Sickle-cell disorders[Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D58 — Other hereditary hemolytic anemias[Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D59 — Acquired hemolytic anemia[Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D60 — Acquired pure red cell aplasia [erythroblastopenia][Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D61 — Other aplastic anemias and other bone marrow failure syndromes[Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D62 — Acute posthemorrhagic anemia[Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D63 — Anemia in chronic diseases classified elsewhere[Code First]: “blood disorders (D56-D76)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- and 24 more
Use Additional Code
- Y63.6 — Underdosing and nonadministration of necessary drug, medicament or biological substance[Use Additional Code]: “underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- Y63.8 — Failure in dosage during other surgical and medical care[Use Additional Code]: “underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- Y63.9 — Failure in dosage during unspecified surgical and medical care[Use Additional Code]: “underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- Z91.12 — Patient's intentional underdosing of medication regimen[Use Additional Code]: “underdosing of medication regimen (Z91.12-, Z91.13-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- Z91.13 — Patient's unintentional underdosing of medication regimen[Use Additional Code]: “underdosing of medication regimen (Z91.12-, Z91.13-)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Referenced by Excludes2 notes (11)
- T80 — Complications following infusion, transfusion and therapeutic injection[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- T80-T88 — Complications of surgical and medical care, not elsewhere classified (T80-T88)[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- T81 — Complications of procedures, not elsewhere classified[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- T82 — Complications of cardiac and vascular prosthetic devices, implants and grafts[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- T83 — Complications of genitourinary prosthetic devices, implants and grafts[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- T84 — Complications of internal orthopedic prosthetic devices, implants and grafts[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- T85 — Complications of other internal prosthetic devices, implants and grafts[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- T86 — Complications of transplanted organs and tissue[Excludes2]: “poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4 or 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- and 3 more
Referenced by Code First instructions (20)
- D64.2 — Secondary sideroblastic anemia due to drugs and toxins[Code First]: “poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- E03.2 — Hypothyroidism due to medicaments and other exogenous substances[Code First]: “poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- E09 — Drug or chemical induced diabetes mellitus[Code First]: “poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- F02 — Dementia in other diseases classified elsewhere[Code First]: “intoxications (T36-T65)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- G92.8 — Other toxic encephalopathy[Code First]: “poisoning due to drug or toxin, if applicable, (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- G92.9 — Unspecified toxic encephalopathy[Code First]: “poisoning due to drug or toxin, if applicable, (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- H35.38 — Toxic maculopathy[Code First]: “poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- H91.0 — Ototoxic hearing loss[Code First]: “poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- and 12 more
Referenced by Use Additional Code instructions (99)
- D46 — Myelodysplastic syndromes[Use Additional Code]: “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D52.1 — Drug-induced folate deficiency anemia[Use Additional Code]: “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D59.0 — Drug-induced autoimmune hemolytic anemia[Use Additional Code]: “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D59.2 — Drug-induced nonautoimmune hemolytic anemia[Use Additional Code]: “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D59.39 — Other hemolytic-uremic syndrome[Use Additional Code]: “code, if applicable, for adverse effect to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D61.1 — Drug-induced aplastic anemia[Use Additional Code]: “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D64.2 — Secondary sideroblastic anemia due to drugs and toxins[Use Additional Code]: “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- D70.2 — Other drug-induced agranulocytosis[Use Additional Code]: “code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
- and 91 more
Referenced by Code Also instructions
- Z91.1 — Patient's noncompliance with medical treatment and regimen[Code Also]: “, if applicable, to identify underdosing of specific drug (T36-T50 with final character 6)”— CMS ICD-10-CM tabular instructional notes · icd10cm-fy2026
Nearest codes (400)
- T43.0 — Poisoning by, adverse effect of and underdosing of tricyclic and tetracyclic antidepressants[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T43.01 — Poisoning by, adverse effect of and underdosing of tricyclic antidepressants[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T43.011 — Poisoning by tricyclic antidepressants, accidental (unintentional)[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T43.011A — Poisoning by tricyclic antidepressants, accidental (unintentional), initial encounter[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T43.011D — Poisoning by tricyclic antidepressants, accidental (unintentional), subsequent encounter[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T43.011S — Poisoning by tricyclic antidepressants, accidental (unintentional), sequela[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T43.012 — Poisoning by tricyclic antidepressants, intentional self-harm[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- T43.012A — Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- and 392 more
Change history
- FY2016 — In the code set at ICD-10-CM adoption [Change history]— CMS release files (code change ledger) · icd10cm-fy2016
Common coding questions
Can T43 be billed directly?
No. T43 (Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified) is a non-billable ICD-10-CM category code. A more specific billable subcode must be selected based on clinical documentation.
Does T43 require a 7th character?
Yes. The appropriate 7th character is to be added to each code from category T43; A: initial encounter; D: subsequent encounter; S: sequela.
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, title, tabular notes and index terms Official source data
- CMS/CDC ICD-10-CM FY2026 tabular list, index and tables, effective October 1, 2025 Release, file and checksum · Publisher’s page
- Claim edits Official source data
- CMS Definitions of Medicare Code Edits — v43.1 (April 2026) Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Change history
- FY2016 — October 1, 2015In the code set at ICD-10-CM adoptionPoisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified
No changes since FY2016 — additions, deletions, description changes and billable-status changes are tracked through FY2027 (effective October 1, 2026), and none are recorded for this code. Note changes are tracked from FY2027 only.
Nearest Codes in This Family
Official ICD-10-CM classifications closest to T43 in its code family, with their registry titles.
- T43.0 — Poisoning by, adverse effect of and underdosing of tricyclic and tetracyclic antidepressants
- T43.01 — Poisoning by, adverse effect of and underdosing of tricyclic antidepressants
- T43.011 — Poisoning by tricyclic antidepressants, accidental (unintentional)
- T43.011A — Poisoning by tricyclic antidepressants, accidental (unintentional), initial encounter
- T43.011D — Poisoning by tricyclic antidepressants, accidental (unintentional), subsequent encounter
- T43.011S — Poisoning by tricyclic antidepressants, accidental (unintentional), sequela
- T43.012 — Poisoning by tricyclic antidepressants, intentional self-harm
- T43.012A — Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter
- T43.012D — Poisoning by tricyclic antidepressants, intentional self-harm, subsequent encounter
- T43.012S — Poisoning by tricyclic antidepressants, intentional self-harm, sequela
- T43.013 — Poisoning by tricyclic antidepressants, assault
- T43.013A — Poisoning by tricyclic antidepressants, assault, initial encounter
- T43.013D — Poisoning by tricyclic antidepressants, assault, subsequent encounter
- T43.013S — Poisoning by tricyclic antidepressants, assault, sequela
- T43.014 — Poisoning by tricyclic antidepressants, undetermined
- T43.014A — Poisoning by tricyclic antidepressants, undetermined, initial encounter
- T43.014D — Poisoning by tricyclic antidepressants, undetermined, subsequent encounter
- T43.014S — Poisoning by tricyclic antidepressants, undetermined, sequela
- T43.015 — Adverse effect of tricyclic antidepressants
- T43.015A — Adverse effect of tricyclic antidepressants, initial encounter
- T43.015D — Adverse effect of tricyclic antidepressants, subsequent encounter
- T43.015S — Adverse effect of tricyclic antidepressants, sequela
- T43.016 — Underdosing of tricyclic antidepressants
- T43.016A — Underdosing of tricyclic antidepressants, initial encounter
- T43.016D — Underdosing of tricyclic antidepressants, subsequent encounter
- T43.016S — Underdosing of tricyclic antidepressants, sequela
- T43.02 — Poisoning by, adverse effect of and underdosing of tetracyclic antidepressants
- T43.021 — Poisoning by tetracyclic antidepressants, accidental (unintentional)
- T43.021A — Poisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter
- T43.021D — Poisoning by tetracyclic antidepressants, accidental (unintentional), subsequent encounter
- T43.021S — Poisoning by tetracyclic antidepressants, accidental (unintentional), sequela
- T43.022 — Poisoning by tetracyclic antidepressants, intentional self-harm
- T43.022A — Poisoning by tetracyclic antidepressants, intentional self-harm, initial encounter
- T43.022D — Poisoning by tetracyclic antidepressants, intentional self-harm, subsequent encounter
- T43.022S — Poisoning by tetracyclic antidepressants, intentional self-harm, sequela
- T43.023 — Poisoning by tetracyclic antidepressants, assault
- T43.023A — Poisoning by tetracyclic antidepressants, assault, initial encounter
- T43.023D — Poisoning by tetracyclic antidepressants, assault, subsequent encounter
- T43.023S — Poisoning by tetracyclic antidepressants, assault, sequela
- T43.024 — Poisoning by tetracyclic antidepressants, undetermined
- T43.024A — Poisoning by tetracyclic antidepressants, undetermined, initial encounter
- T43.024D — Poisoning by tetracyclic antidepressants, undetermined, subsequent encounter
- T43.024S — Poisoning by tetracyclic antidepressants, undetermined, sequela
- T43.025 — Adverse effect of tetracyclic antidepressants
- T43.025A — Adverse effect of tetracyclic antidepressants, initial encounter
- T43.025D — Adverse effect of tetracyclic antidepressants, subsequent encounter
- T43.025S — Adverse effect of tetracyclic antidepressants, sequela
- T43.026 — Underdosing of tetracyclic antidepressants
- T43.026A — Underdosing of tetracyclic antidepressants, initial encounter
- T43.026D — Underdosing of tetracyclic antidepressants, subsequent encounter
- T43.026S — Underdosing of tetracyclic antidepressants, sequela
- T43.1 — Poisoning by, adverse effect of and underdosing of monoamine-oxidase-inhibitor antidepressants
- T43.1X — Poisoning by, adverse effect of and underdosing of monoamine-oxidase-inhibitor antidepressants
- T43.1X1 — Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional)
- T43.1X1A — Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
- T43.1X1D — Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), subsequent encounter
- T43.1X1S — Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), sequela
- T43.1X2 — Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm
- T43.1X2A — Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
- T43.1X2D — Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, subsequent encounter
- T43.1X2S — Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, sequela
- T43.1X3 — Poisoning by monoamine-oxidase-inhibitor antidepressants, assault
- T43.1X3A — Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter
- T43.1X3D — Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, subsequent encounter
- T43.1X3S — Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, sequela
- T43.1X4 — Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined
- T43.1X4A — Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter
- T43.1X4D — Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, subsequent encounter
- T43.1X4S — Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, sequela
- T43.1X5 — Adverse effect of monoamine-oxidase-inhibitor antidepressants
- T43.1X5A — Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
- T43.1X5D — Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
- T43.1X5S — Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
- T43.1X6 — Underdosing of monoamine-oxidase-inhibitor antidepressants
- T43.1X6A — Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter
- T43.1X6D — Underdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
- T43.1X6S — Underdosing of monoamine-oxidase-inhibitor antidepressants, sequela
- T43.2 — Poisoning by, adverse effect of and underdosing of other and unspecified antidepressants
- T43.20 — Poisoning by, adverse effect of and underdosing of unspecified antidepressants
- T43.201 — Poisoning by unspecified antidepressants, accidental (unintentional)
- T43.201A — Poisoning by unspecified antidepressants, accidental (unintentional), initial encounter
- T43.201D — Poisoning by unspecified antidepressants, accidental (unintentional), subsequent encounter
- T43.201S — Poisoning by unspecified antidepressants, accidental (unintentional), sequela
- T43.202 — Poisoning by unspecified antidepressants, intentional self-harm
- T43.202A — Poisoning by unspecified antidepressants, intentional self-harm, initial encounter
- T43.202D — Poisoning by unspecified antidepressants, intentional self-harm, subsequent encounter
- T43.202S — Poisoning by unspecified antidepressants, intentional self-harm, sequela
- T43.203 — Poisoning by unspecified antidepressants, assault
- T43.203A — Poisoning by unspecified antidepressants, assault, initial encounter
- T43.203D — Poisoning by unspecified antidepressants, assault, subsequent encounter
- T43.203S — Poisoning by unspecified antidepressants, assault, sequela
- T43.204 — Poisoning by unspecified antidepressants, undetermined
- T43.204A — Poisoning by unspecified antidepressants, undetermined, initial encounter
- T43.204D — Poisoning by unspecified antidepressants, undetermined, subsequent encounter
- T43.204S — Poisoning by unspecified antidepressants, undetermined, sequela
- T43.205 — Adverse effect of unspecified antidepressants
- T43.205A — Adverse effect of unspecified antidepressants, initial encounter
- T43.205D — Adverse effect of unspecified antidepressants, subsequent encounter
- T43.205S — Adverse effect of unspecified antidepressants, sequela
- T43.206 — Underdosing of unspecified antidepressants
- T43.206A — Underdosing of unspecified antidepressants, initial encounter
- T43.206D — Underdosing of unspecified antidepressants, subsequent encounter
- T43.206S — Underdosing of unspecified antidepressants, sequela
- T43.21 — Poisoning by, adverse effect of and underdosing of selective serotonin and norepinephrine reuptake inhibitors
- T43.211 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional)
- T43.211A — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter
- T43.211D — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), subsequent encounter
- T43.211S — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), sequela
- T43.212 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm
- T43.212A — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter
- T43.212D — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, subsequent encounter
- T43.212S — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, sequela
- T43.213 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault
- T43.213A — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter
- T43.213D — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, subsequent encounter
- T43.213S — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, sequela
- T43.214 — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined
- T43.214A — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter
- T43.214D — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, subsequent encounter
- T43.214S — Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, sequela
- T43.215 — Adverse effect of selective serotonin and norepinephrine reuptake inhibitors
- T43.215A — Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
- T43.215D — Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
- T43.215S — Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
- T43.216 — Underdosing of selective serotonin and norepinephrine reuptake inhibitors
- T43.216A — Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
- T43.216D — Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
- T43.216S — Underdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela
- T43.22 — Poisoning by, adverse effect of and underdosing of selective serotonin reuptake inhibitors
- T43.221 — Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional)
- T43.221A — Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter
- T43.221D — Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), subsequent encounter
- T43.221S — Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), sequela
- T43.222 — Poisoning by selective serotonin reuptake inhibitors, intentional self-harm
- T43.222A — Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter
- T43.222D — Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, subsequent encounter
- T43.222S — Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, sequela
- T43.223 — Poisoning by selective serotonin reuptake inhibitors, assault
- T43.223A — Poisoning by selective serotonin reuptake inhibitors, assault, initial encounter
- T43.223D — Poisoning by selective serotonin reuptake inhibitors, assault, subsequent encounter
- T43.223S — Poisoning by selective serotonin reuptake inhibitors, assault, sequela
- T43.224 — Poisoning by selective serotonin reuptake inhibitors, undetermined
- T43.224A — Poisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter
- T43.224D — Poisoning by selective serotonin reuptake inhibitors, undetermined, subsequent encounter
- T43.224S — Poisoning by selective serotonin reuptake inhibitors, undetermined, sequela
- T43.225 — Adverse effect of selective serotonin reuptake inhibitors
- T43.225A — Adverse effect of selective serotonin reuptake inhibitors, initial encounter
- T43.225D — Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
- T43.225S — Adverse effect of selective serotonin reuptake inhibitors, sequela
- T43.226 — Underdosing of selective serotonin reuptake inhibitors
- T43.226A — Underdosing of selective serotonin reuptake inhibitors, initial encounter
- T43.226D — Underdosing of selective serotonin reuptake inhibitors, subsequent encounter
- T43.226S — Underdosing of selective serotonin reuptake inhibitors, sequela
- T43.29 — Poisoning by, adverse effect of and underdosing of other antidepressants
- T43.291 — Poisoning by other antidepressants, accidental (unintentional)
- T43.291A — Poisoning by other antidepressants, accidental (unintentional), initial encounter
- T43.291D — Poisoning by other antidepressants, accidental (unintentional), subsequent encounter
- T43.291S — Poisoning by other antidepressants, accidental (unintentional), sequela
- T43.292 — Poisoning by other antidepressants, intentional self-harm
- T43.292A — Poisoning by other antidepressants, intentional self-harm, initial encounter
- T43.292D — Poisoning by other antidepressants, intentional self-harm, subsequent encounter
- T43.292S — Poisoning by other antidepressants, intentional self-harm, sequela
- T43.293 — Poisoning by other antidepressants, assault
- T43.293A — Poisoning by other antidepressants, assault, initial encounter
- T43.293D — Poisoning by other antidepressants, assault, subsequent encounter
- T43.293S — Poisoning by other antidepressants, assault, sequela
- T43.294 — Poisoning by other antidepressants, undetermined
- T43.294A — Poisoning by other antidepressants, undetermined, initial encounter
- T43.294D — Poisoning by other antidepressants, undetermined, subsequent encounter
- T43.294S — Poisoning by other antidepressants, undetermined, sequela
- T43.295 — Adverse effect of other antidepressants
- T43.295A — Adverse effect of other antidepressants, initial encounter
- T43.295D — Adverse effect of other antidepressants, subsequent encounter
- T43.295S — Adverse effect of other antidepressants, sequela
- T43.296 — Underdosing of other antidepressants
- T43.296A — Underdosing of other antidepressants, initial encounter
- T43.296D — Underdosing of other antidepressants, subsequent encounter
- T43.296S — Underdosing of other antidepressants, sequela
- T43.3 — Poisoning by, adverse effect of and underdosing of phenothiazine antipsychotics and neuroleptics
- T43.3X — Poisoning by, adverse effect of and underdosing of phenothiazine antipsychotics and neuroleptics
- T43.3X1 — Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional)
- T43.3X1A — Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter
- T43.3X1D — Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
- T43.3X1S — Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), sequela
- T43.3X2 — Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm
- T43.3X2A — Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter
- T43.3X2D — Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
- T43.3X2S — Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, sequela
- T43.3X3 — Poisoning by phenothiazine antipsychotics and neuroleptics, assault
- T43.3X3A — Poisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter
- T43.3X3D — Poisoning by phenothiazine antipsychotics and neuroleptics, assault, subsequent encounter
- T43.3X3S — Poisoning by phenothiazine antipsychotics and neuroleptics, assault, sequela
- T43.3X4 — Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined
- T43.3X4A — Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter
- T43.3X4D — Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, subsequent encounter
- T43.3X4S — Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, sequela
- T43.3X5 — Adverse effect of phenothiazine antipsychotics and neuroleptics
- T43.3X5A — Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
- T43.3X5D — Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
- T43.3X5S — Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
- T43.3X6 — Underdosing of phenothiazine antipsychotics and neuroleptics
- T43.3X6A — Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter
- T43.3X6D — Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter
- T43.3X6S — Underdosing of phenothiazine antipsychotics and neuroleptics, sequela
- T43.4 — Poisoning by, adverse effect of and underdosing of butyrophenone and thiothixene neuroleptics
- T43.4X — Poisoning by, adverse effect of and underdosing of butyrophenone and thiothixene neuroleptics
- T43.4X1 — Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional)
- T43.4X1A — Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
- T43.4X1D — Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), subsequent encounter
- T43.4X1S — Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), sequela
- T43.4X2 — Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm
- T43.4X2A — Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter
- T43.4X2D — Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, subsequent encounter
- T43.4X2S — Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, sequela
- T43.4X3 — Poisoning by butyrophenone and thiothixene neuroleptics, assault
- T43.4X3A — Poisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter
- T43.4X3D — Poisoning by butyrophenone and thiothixene neuroleptics, assault, subsequent encounter
- T43.4X3S — Poisoning by butyrophenone and thiothixene neuroleptics, assault, sequela
- T43.4X4 — Poisoning by butyrophenone and thiothixene neuroleptics, undetermined
- T43.4X4A — Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter
- T43.4X4D — Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, subsequent encounter
- T43.4X4S — Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, sequela
- T43.4X5 — Adverse effect of butyrophenone and thiothixene neuroleptics
- T43.4X5A — Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
- T43.4X5D — Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
- T43.4X5S — Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
- T43.4X6 — Underdosing of butyrophenone and thiothixene neuroleptics
- T43.4X6A — Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter
- T43.4X6D — Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter
- T43.4X6S — Underdosing of butyrophenone and thiothixene neuroleptics, sequela
- T43.5 — Poisoning by, adverse effect of and underdosing of other and unspecified antipsychotics and neuroleptics
- T43.50 — Poisoning by, adverse effect of and underdosing of unspecified antipsychotics and neuroleptics
- T43.501 — Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional)
- T43.501A — Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter
- T43.501D — Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
- T43.501S — Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), sequela
- T43.502 — Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm
- T43.502A — Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter
- T43.502D — Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
- T43.502S — Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, sequela
- T43.503 — Poisoning by unspecified antipsychotics and neuroleptics, assault
- T43.503A — Poisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter
- T43.503D — Poisoning by unspecified antipsychotics and neuroleptics, assault, subsequent encounter
- T43.503S — Poisoning by unspecified antipsychotics and neuroleptics, assault, sequela
- T43.504 — Poisoning by unspecified antipsychotics and neuroleptics, undetermined
- T43.504A — Poisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter
- T43.504D — Poisoning by unspecified antipsychotics and neuroleptics, undetermined, subsequent encounter
- T43.504S — Poisoning by unspecified antipsychotics and neuroleptics, undetermined, sequela
- T43.505 — Adverse effect of unspecified antipsychotics and neuroleptics
- T43.505A — Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
- T43.505D — Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
- T43.505S — Adverse effect of unspecified antipsychotics and neuroleptics, sequela
- T43.506 — Underdosing of unspecified antipsychotics and neuroleptics
- T43.506A — Underdosing of unspecified antipsychotics and neuroleptics, initial encounter
- T43.506D — Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter
- T43.506S — Underdosing of unspecified antipsychotics and neuroleptics, sequela
- T43.59 — Poisoning by, adverse effect of and underdosing of other antipsychotics and neuroleptics
- T43.591 — Poisoning by other antipsychotics and neuroleptics, accidental (unintentional)
- T43.591A — Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter
- T43.591D — Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter
- T43.591S — Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), sequela
- T43.592 — Poisoning by other antipsychotics and neuroleptics, intentional self-harm
- T43.592A — Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter
- T43.592D — Poisoning by other antipsychotics and neuroleptics, intentional self-harm, subsequent encounter
- T43.592S — Poisoning by other antipsychotics and neuroleptics, intentional self-harm, sequela
- T43.593 — Poisoning by other antipsychotics and neuroleptics, assault
- T43.593A — Poisoning by other antipsychotics and neuroleptics, assault, initial encounter
- T43.593D — Poisoning by other antipsychotics and neuroleptics, assault, subsequent encounter
- T43.593S — Poisoning by other antipsychotics and neuroleptics, assault, sequela
- T43.594 — Poisoning by other antipsychotics and neuroleptics, undetermined
- T43.594A — Poisoning by other antipsychotics and neuroleptics, undetermined, initial encounter
- T43.594D — Poisoning by other antipsychotics and neuroleptics, undetermined, subsequent encounter
- T43.594S — Poisoning by other antipsychotics and neuroleptics, undetermined, sequela
- T43.595 — Adverse effect of other antipsychotics and neuroleptics
- T43.595A — Adverse effect of other antipsychotics and neuroleptics, initial encounter
- T43.595D — Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
- T43.595S — Adverse effect of other antipsychotics and neuroleptics, sequela
- T43.596 — Underdosing of other antipsychotics and neuroleptics
- T43.596A — Underdosing of other antipsychotics and neuroleptics, initial encounter
- T43.596D — Underdosing of other antipsychotics and neuroleptics, subsequent encounter
- T43.596S — Underdosing of other antipsychotics and neuroleptics, sequela
- T43.6 — Poisoning by, adverse effect of and underdosing of psychostimulants
- T43.60 — Poisoning by, adverse effect of and underdosing of unspecified psychostimulant
- T43.601 — Poisoning by unspecified psychostimulants, accidental (unintentional)
- T43.601A — Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter
- T43.601D — Poisoning by unspecified psychostimulants, accidental (unintentional), subsequent encounter
- T43.601S — Poisoning by unspecified psychostimulants, accidental (unintentional), sequela
- T43.602 — Poisoning by unspecified psychostimulants, intentional self-harm
- T43.602A — Poisoning by unspecified psychostimulants, intentional self-harm, initial encounter
- T43.602D — Poisoning by unspecified psychostimulants, intentional self-harm, subsequent encounter
- T43.602S — Poisoning by unspecified psychostimulants, intentional self-harm, sequela
- T43.603 — Poisoning by unspecified psychostimulants, assault
- T43.603A — Poisoning by unspecified psychostimulants, assault, initial encounter
- T43.603D — Poisoning by unspecified psychostimulants, assault, subsequent encounter
- T43.603S — Poisoning by unspecified psychostimulants, assault, sequela
- T43.604 — Poisoning by unspecified psychostimulants, undetermined
- T43.604A — Poisoning by unspecified psychostimulants, undetermined, initial encounter
- T43.604D — Poisoning by unspecified psychostimulants, undetermined, subsequent encounter
- T43.604S — Poisoning by unspecified psychostimulants, undetermined, sequela
- T43.605 — Adverse effect of unspecified psychostimulants
- T43.605A — Adverse effect of unspecified psychostimulants, initial encounter
- T43.605D — Adverse effect of unspecified psychostimulants, subsequent encounter
- T43.605S — Adverse effect of unspecified psychostimulants, sequela
- T43.606 — Underdosing of unspecified psychostimulants
- T43.606A — Underdosing of unspecified psychostimulants, initial encounter
- T43.606D — Underdosing of unspecified psychostimulants, subsequent encounter
- T43.606S — Underdosing of unspecified psychostimulants, sequela
- T43.61 — Poisoning by, adverse effect of and underdosing of caffeine
- T43.611 — Poisoning by caffeine, accidental (unintentional)
- T43.611A — Poisoning by caffeine, accidental (unintentional), initial encounter
- T43.611D — Poisoning by caffeine, accidental (unintentional), subsequent encounter
- T43.611S — Poisoning by caffeine, accidental (unintentional), sequela
- T43.612 — Poisoning by caffeine, intentional self-harm
- T43.612A — Poisoning by caffeine, intentional self-harm, initial encounter
- T43.612D — Poisoning by caffeine, intentional self-harm, subsequent encounter
- T43.612S — Poisoning by caffeine, intentional self-harm, sequela
- T43.613 — Poisoning by caffeine, assault
- T43.613A — Poisoning by caffeine, assault, initial encounter
- T43.613D — Poisoning by caffeine, assault, subsequent encounter
- T43.613S — Poisoning by caffeine, assault, sequela
- T43.614 — Poisoning by caffeine, undetermined
- T43.614A — Poisoning by caffeine, undetermined, initial encounter
- T43.614D — Poisoning by caffeine, undetermined, subsequent encounter
- T43.614S — Poisoning by caffeine, undetermined, sequela
- T43.615 — Adverse effect of caffeine
- T43.615A — Adverse effect of caffeine, initial encounter
- T43.615D — Adverse effect of caffeine, subsequent encounter
- T43.615S — Adverse effect of caffeine, sequela
- T43.616 — Underdosing of caffeine
- T43.616A — Underdosing of caffeine, initial encounter
- T43.616D — Underdosing of caffeine, subsequent encounter
- T43.616S — Underdosing of caffeine, sequela
- T43.62 — Poisoning by, adverse effect of and underdosing of amphetamines
- T43.621 — Poisoning by amphetamines, accidental (unintentional)
- T43.621A — Poisoning by amphetamines, accidental (unintentional), initial encounter
- T43.621D — Poisoning by amphetamines, accidental (unintentional), subsequent encounter
- T43.621S — Poisoning by amphetamines, accidental (unintentional), sequela
- T43.622 — Poisoning by amphetamines, intentional self-harm
- T43.622A — Poisoning by amphetamines, intentional self-harm, initial encounter
- T43.622D — Poisoning by amphetamines, intentional self-harm, subsequent encounter
- T43.622S — Poisoning by amphetamines, intentional self-harm, sequela
- T43.623 — Poisoning by amphetamines, assault
- T43.623A — Poisoning by amphetamines, assault, initial encounter
- T43.623D — Poisoning by amphetamines, assault, subsequent encounter
- T43.623S — Poisoning by amphetamines, assault, sequela
- T43.624 — Poisoning by amphetamines, undetermined
- T43.624A — Poisoning by amphetamines, undetermined, initial encounter
- T43.624D — Poisoning by amphetamines, undetermined, subsequent encounter
- T43.624S — Poisoning by amphetamines, undetermined, sequela
- T43.625 — Adverse effect of amphetamines
- T43.625A — Adverse effect of amphetamines, initial encounter
- T43.625D — Adverse effect of amphetamines, subsequent encounter
- T43.625S — Adverse effect of amphetamines, sequela
- T43.626 — Underdosing of amphetamines
- T43.626A — Underdosing of amphetamines, initial encounter
- T43.626D — Underdosing of amphetamines, subsequent encounter
- T43.626S — Underdosing of amphetamines, sequela
- T43.63 — Poisoning by, adverse effect of and underdosing of methylphenidate
- T43.631 — Poisoning by methylphenidate, accidental (unintentional)
- T43.631A — Poisoning by methylphenidate, accidental (unintentional), initial encounter
- T43.631D — Poisoning by methylphenidate, accidental (unintentional), subsequent encounter
- T43.631S — Poisoning by methylphenidate, accidental (unintentional), sequela
- T43.632 — Poisoning by methylphenidate, intentional self-harm
- T43.632A — Poisoning by methylphenidate, intentional self-harm, initial encounter
- T43.632D — Poisoning by methylphenidate, intentional self-harm, subsequent encounter
- T43.632S — Poisoning by methylphenidate, intentional self-harm, sequela
- T43.633 — Poisoning by methylphenidate, assault
- T43.633A — Poisoning by methylphenidate, assault, initial encounter
- T43.633D — Poisoning by methylphenidate, assault, subsequent encounter
- T43.633S — Poisoning by methylphenidate, assault, sequela
- T43.634 — Poisoning by methylphenidate, undetermined
- T43.634A — Poisoning by methylphenidate, undetermined, initial encounter
- T43.634D — Poisoning by methylphenidate, undetermined, subsequent encounter
- T43.634S — Poisoning by methylphenidate, undetermined, sequela
- T43.635 — Adverse effect of methylphenidate
- T43.635A — Adverse effect of methylphenidate, initial encounter
- T43.635D — Adverse effect of methylphenidate, subsequent encounter
- T43.635S — Adverse effect of methylphenidate, sequela
- T43.636 — Underdosing of methylphenidate
- T43.636A — Underdosing of methylphenidate, initial encounter
- T43.636D — Underdosing of methylphenidate, subsequent encounter
- T43.636S — Underdosing of methylphenidate, sequela
- T43.64 — Poisoning by ecstasy
- T43.641 — Poisoning by ecstasy, accidental (unintentional)
- T43.641A — Poisoning by ecstasy, accidental (unintentional), initial encounter
- T43.641D — Poisoning by ecstasy, accidental (unintentional), subsequent encounter
- T43.641S — Poisoning by ecstasy, accidental (unintentional), sequela
- T43.642 — Poisoning by ecstasy, intentional self-harm
- T43.642A — Poisoning by ecstasy, intentional self-harm, initial encounter
- T43.642D — Poisoning by ecstasy, intentional self-harm, subsequent encounter
- T43.642S — Poisoning by ecstasy, intentional self-harm, sequela
- T43.643 — Poisoning by ecstasy, assault
- T43.643A — Poisoning by ecstasy, assault, initial encounter
- T43.643D — Poisoning by ecstasy, assault, subsequent encounter
- T43.643S — Poisoning by ecstasy, assault, sequela
- T43.644 — Poisoning by ecstasy, undetermined
- T43.644A — Poisoning by ecstasy, undetermined, initial encounter
- T43.644D — Poisoning by ecstasy, undetermined, subsequent encounter
- T43.644S — Poisoning by ecstasy, undetermined, sequela
- T43.65 — Poisoning by, adverse effect of and underdosing of methamphetamines